title: Fibrinolytic therapy for parapneumonic empyema during pregnancy.
abstract: Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Herein, we describe the cases of two pregnant women with parapneumonic empyema who were successfully treated with intrapleural fibrinolytic therapy.
authors.affiliation: Department of Thoracic Surgery, School of Medicine, Inonu University, Malatya, Turkey.
authors.forename: Hakki
authors.initials: H
authors.lastname: Ulutas
authors.affiliation: Department of Thoracic Surgery, Ataturk Training and Research Hospital for Chest Disease and Chest Surgery, Kecioren, Ankara, Turkey.
authors.forename: Erdal
authors.initials: E
authors.lastname: Yekeler
authors.affiliation: Department of Pulmonary Medicine, School of Medicine, Harran University, Sanliurfa, Turkey.
authors.forename: Zafer Hasan
authors.initials: ZH
authors.lastname: Ali Sak
authors.affiliation: Department of Radiology, Region Training and Research Hospital, Erzurum, Turkey.
authors.forename: Ihsan
authors.initials: I
authors.lastname: Doru
authors.affiliation: Department of Thoracic Surgery, School of Medicine, Inonu University, Malatya, Turkey.
authors.forename: Akin
authors.initials: A
authors.lastname: Kuzucu
keywords: Intrapleural fibrinolytic therapy; Parapneumonic empyema; Pregnancy